Digital Pharmaceutical Sciences

被引:40
作者
Damiati, Safa A. [1 ]
机构
[1] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, POB 80260, Jeddah 21589, Saudi Arabia
关键词
artificial intelligence; machine learning; artificial neural networks; pharmaceutical sciences; pharmaceutical industry; ARTIFICIAL NEURAL-NETWORKS; ACTIVITY-RELATIONSHIP QSAR; BIG DATA; PREDICTION; FORMULATION; OPTIMIZATION; INTELLIGENCE; INGREDIENTS; SOLUBILITY; DRUGS;
D O I
10.1208/s12249-020-01747-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Artificial intelligence (AI) and machine learning, in particular, have gained significant interest in many fields, including pharmaceutical sciences. The enormous growth of data from several sources, the recent advances in various analytical tools, and the continuous developments in machine learning algorithms have resulted in a rapid increase in new machine learning applications in different areas of pharmaceutical sciences. This review summarizes the past, present, and potential future impacts of machine learning technologies on different areas of pharmaceutical sciences, including drug design and discovery, preformulation, and formulation. The machine learning methods commonly used in pharmaceutical sciences are discussed, with a specific emphasis on artificial neural networks due to their capability to model the nonlinear relationships that are commonly encountered in pharmaceutical research. AI and machine learning technologies in common day-to-day pharma needs as well as industrial and regulatory insights are reviewed. Beyond traditional potentials of implementing digital technologies using machine learning in the development of more efficient, fast, and economical solutions in pharmaceutical sciences are also discussed.
引用
收藏
页数:12
相关论文
共 97 条
[1]   Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research [J].
Agatonovic-Kustrin, S ;
Beresford, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (05) :717-727
[2]  
Ali J, 2012, INT J COMP SCI ISSUE, V9, P5
[3]   Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data [J].
Aliper, Alexander ;
Plis, Sergey ;
Artemov, Artem ;
Ulloa, Alvaro ;
Mamoshina, Polina ;
Zhavoronkov, Alex .
MOLECULAR PHARMACEUTICS, 2016, 13 (07) :2524-2530
[4]  
AOYAMA T, 1991, CHEM PHARM BULL, V39, P358
[5]   NEURAL NETWORKS APPLIED TO STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
AOYAMA, T ;
SUZUKI, Y ;
ICHIKAWA, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :905-908
[6]   Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals [J].
Babu, N. Jagadeesh ;
Nangia, Ashwini .
CRYSTAL GROWTH & DESIGN, 2011, 11 (07) :2662-2679
[7]   Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming [J].
Barmpalexis, Panagiotis ;
Grypioti, Agni ;
Eleftheriadis, Georgios K. ;
Fatouros, Dimitris G. .
AAPS PHARMSCITECH, 2018, 19 (02) :741-752
[8]   Simultaneous determination of vitamins C, B6 and PP in pharmaceutics using differential pulse voltammetry with a glassy carbon electrode and multivariate calibration tools [J].
Barthus, RC ;
Mazo, LH ;
Poppi, RJ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 38 (01) :94-99
[9]   DECISION TREES DO NOT GENERALIZE TO NEW VARIATIONS [J].
Bengio, Yoshua ;
Delalleau, Olivier ;
Simard, Clarence .
COMPUTATIONAL INTELLIGENCE, 2010, 26 (04) :449-467
[10]   EVENT-DEPENDENT CONTROL OF NOISE ENHANCES LEARNING IN NEURAL NETWORKS [J].
BURTON, RM ;
MPITSOS, GJ .
NEURAL NETWORKS, 1992, 5 (04) :627-637